Bilateral lacrimal gland enlargement due to post-transplant lymphoproliferative disorder.
Cheung
D
D
Prabhakaran
V
V
Brown
L
L
Stitson
R N M
RN
Sampath
R
R
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D016572:Cyclosporine / Q000009:adverse effects; D020031:Epstein-Barr Virus Infections; D006801:Humans; D007150:Immunohistochemistry; D007155:Immunologic Factors / Q000627:therapeutic use*; D016030:Kidney Transplantation; D007766:Lacrimal Apparatus Diseases / Q000473:pathology / Q000821:virology*; D008232:Lymphoproliferative Disorders / Q000473:pathology / Q000821:virology*; D008297:Male; D008875:Middle Aged; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab; D016572:Cyclosporine